Abstracts tagged "depression"

Abstract Number: 2078 • 2015 ACR/ARHP Annual Meeting
Reserve Capacity: Explaining the Link Between Socioeconomic Status and Depression/Anxiety Among Patients with Systemic Lupus Erythematosus
Desiree Azizoddin¹, Julia Ayeroff², Geraldine Zamora-Racaza³, Taylor Draper⁴, Sarah R. Ormseth⁵, Michael H. Weisman⁶, Lekeisha Sumner⁷ and Perry M. Nicassio⁸, ¹Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, ²Postbaccalaureate Premedical Program, University of Southern California, Los Angeles, CA, CA, ³Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁴Psychology, Loma Linda University, Loma Linda, CA, ⁵Cousins Center for PNI, University of California, Los Angeles, Los Angeles, CA, ⁶Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁷Department of Psychology,, Alliant University, Alhambra, CA, ⁸Cousins Center for PNI, UCLA, LA, CA
Background/Purpose: The purpose of this study was to assess the influence of socioeconomic status (SES) and measures of reserve capacity on depression and anxiety in…
Abstract Number: 2163 • 2015 ACR/ARHP Annual Meeting
Associations Between Sex Differences, Pain, Insomnia, and Depression in Older Adults with Osteoarthritis: A Cross-Sectional Study
Minhui Liu¹, Susan McCurry¹, Michael Vitiello², Basia Belza¹ and Michael Von Korff³, ¹University of Washington School of Nursing, Seattle, WA, ²Psychiatry and Behavioral Sciences, Biobehavioral Nursing and Health Systems, University of Washington School of Medicine, Seattle, WA, ³Group Health Research Institute, Seattle, WA
Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis and affects nearly 30 million Americans. Chronic pain is the major symptom in OA and…
Abstract Number: 2282 • 2015 ACR/ARHP Annual Meeting
“Doing Every-Day Life” with Primary Sjögren’s Syndrome: Factors Predicting Difficulties Performing Daily Activities and Taking on Life Roles
Katie Hackett¹, Dennis W Lendrem², Tim Rapley³, Katherine Deane⁴, Vincent Deary⁵, Simon Bowman⁶, Julia Newton⁷, Wan-Fai Ng⁸ and on behalf of the United Kingdom Primary Sjogren's Syndrome Registry, ¹Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, ²Institute of Cellular Medicine (Musculoskeletal Research Group), NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne, United Kingdom, ³Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom, ⁴University of East Anglia, Norwich, United Kingdom, ⁵School of Health Psychology, Northumbia University, Newcastle upon Tyne, United Kingdom, ⁶Rheumatology Dept, University Hospital Birmingham, Birmingham, United Kingdom, ⁷Newcastle University, Newcastle upon Tyne, United Kingdom, ⁸Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Background/Purpose: Primary Sjögren’s Syndrome (pSS) is an autoimmune disease which targets secretory glands and results in dryness. In addition pSS patients frequently experience symptoms of…
Abstract Number: 2476 • 2015 ACR/ARHP Annual Meeting
Patient-Reported Cognitive Impairment, Pain, and Depressive Symptoms in Patients with Systemic Lupus Erythematosus and Comorbid Depression
Kelly Beck¹, Xing Gao², Yu Cheng³ and Carol M. Greco⁴, ¹School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, ²Biostatistics, University of Pittsburgh, Pittsburgh, PA, ³Biostatistics and Psychiatry, University of Pittsburgh, Pittsburgh, PA, ⁴University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Patients with systemic lupus erythematosus (SLE) frequently report cognitive impairment as well as depressive symptoms and significant pain. However, depression criteria and SLE symptoms…
Abstract Number: 1116 • 2014 ACR/ARHP Annual Meeting
Mindfulness Is Associated with Sleep Quality Among Patients with Fibromyalgia
Yuan Zhang¹, Lori Lyn Price², Nani Morgan³, Lucas Morgan⁴ and Chenchen Wang⁵, ¹School of Nursing, University of Massachusetts Lowell, Lowell, MA, ²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ³Internal Medicine Residency Program, University of Hawaii, Honolulu, HI, ⁴Clinical Psychology, University of Massachusetts, Honolulu, HI, ⁵Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Mindfulness is the ability to observe, describe, or be aware of present moment experiences without judgment or reactivity. Previous literature suggests that mindfulness-based interventions…
Abstract Number: 1108 • 2014 ACR/ARHP Annual Meeting
Understanding Baseline Clinical Characteristics May be of Use in Considering the Response to Pregabalin in FM Patients with Comorbid Depression
Lynne Pauer¹, Jaren Landen², Pritha Bhadra Brown³, Joseph Scavone², Richard Vissing⁴ and Andrew Clair³, ¹445 Eastern Point Road, Pfizer Inc, Groton, CT, ²Pfizer Inc, Groton, CT, ³Pfizer Inc, New York, NY, ⁴Pfizer Inc, Louisville, KY
Background/Purpose In a prior study in fibromyalgia (FM) patients taking an antidepressant for their comorbid depression, pregabalin (PGB) significantly reduced pain severity (treatment difference compared…
Abstract Number: 1084 • 2014 ACR/ARHP Annual Meeting
Obesity Is a Risk Factor for Depression in Systemic Lupus Erythematosus (SLE)
Patricia P. Katz¹, Stephanie Rush², Laura Trupin³, Jennifer Barton³, Gabriela Schmajuk³, Jinoos Yazdany³, Chris Tonner⁴ and Mary Margaretten³, ¹Medicine, University of California, San Francisco, CA, ²University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA, ⁴3333 California Street, Box 09, University of California, San Francisco, San Francisco, CA
Background/Purpose: General population studies have found significant relationships between obesity and depression, including identifying obesity as a risk factor for onset of depression. In SLE,…
Abstract Number: 1094 • 2014 ACR/ARHP Annual Meeting
Work Productivity and Healthcare Utilization in Patients with Fibromyalgia and Comorbid Depression Taking Antidepressant Medication
Jaren Landen¹, Claire Burbridge², Elizabeth Masters³, Pritha Bhadra Brown⁴, Joseph Scavone¹, Birol Emir⁴, Richard Vissing⁵, Andrew Clair⁴ and Lynne Pauer⁶, ¹Pfizer Inc, Groton, CT, ²Pfizer Ltd, Walton Oaks, United Kingdom, ³Health Economics and Outcomes Research, Pfizer Inc, New York, NY, ⁴Pfizer Inc, New York, NY, ⁵Pfizer Inc, Louisville, KY, ⁶445 Eastern Point Road, Pfizer Inc, Groton, CT
Background/Purpose Patients with fibromyalgia (FM) experience pain, sleep disruption, fatigue, and other symptoms that limit activity, impacting work productivity and increasing healthcare utilization. Here, we…
Abstract Number: 2943 • 2014 ACR/ARHP Annual Meeting
Severity of Foot Pain Is Linked to the Prevalence of Depressive Symptoms: The Framingham Foot Study
Arunima Awale¹, Alyssa B. Dufour², Patricia P. Katz³, Virginia A. Casey¹ and Marian T. Hannan⁴, ¹Institute for Aging Research, Hebrew SeniorLife, Boston, MA, ²Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA, ³Medicine, University of California, San Francisco, CA, ⁴Institute for Aging Research, Hebrew SeniorLife, Dept. of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Background/Purpose: While a number of risk factors for foot pain are established, the relation between depression and foot pain has not been well studied. The…
Abstract Number: 2760 • 2014 ACR/ARHP Annual Meeting
Interferon Alfa-Associated Depression in Patients with Behçet’s Syndrome
Yasin Keskin¹, Emire Seyahi², Cagri Poyraz³, Serdal Ugurlu¹, Yilmaz Ozyazgan⁴ and Hasan Yazici⁵, ¹Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ²Division of Rheumatology,Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ³Department of Psychiatry, Cerrahpasa Medical Faculty, University Of Istanbul, Istanbul, Istanbul, Turkey, ⁴Department of Ophthalmology, Cerrahpasa Medical Faculty University of Istanbul, Istanbul, Turkey, ⁵Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey
Background/Purpose: Interferon (IFN) is an effective immune-modulatory agent in the medical management of eye disease of Behçet’s syndrome (BS). The agent is frequently associated with…
Abstract Number: 2658 • 2014 ACR/ARHP Annual Meeting
Cognitive Symptoms and Associated Disease and Non-Disease Related Factors in Patients with Systemic Lupus Erythematosus : A Longitudinal Study
Yang Gao, Yi Lo and Mo Yin Mok, Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: Cognitive impairment is commonly reported in patients with systemic lupus erythematosus (SLE). Its associated disease and non-disease related factors have been inconsistently reported. Objective:…
Abstract Number: 2646 • 2014 ACR/ARHP Annual Meeting
Mood Disorders in Systemic Lupus Erythematousus (SLE): Results from an International, Inception Cohort Study
John G. Hanly for the Systemic Lupus International Collaborating Clinics¹, Li Su², Murray Urowitz³, Juanita Romero-Diaz⁴, Caroline Gordon⁵, Sang-Cheol Bae⁶, Sasha R Bernatsky⁷, Ann E. Clarke⁸, Daniel J. Wallace⁹, Joan T. Merrill¹⁰, David A. Isenberg¹¹, Anisur Rahman¹², Ellen M. Ginzler¹³, Paul Fortin¹⁴, Dafna D. Gladman¹⁵, Jorge Sanchez-Guerrero¹⁶, Michelle Petri¹⁷, Ian Bruce¹⁸, Mary Anne Dooley¹⁹, Rosalind Ramsey-Goldman²⁰, Cynthia Aranow²¹, Graciela S. Alarcon²², Barri J. Fessler²³, Kristján Steinsson²⁴, Ola Nived²⁵, Gunnar K. Sturfelt²⁵, Susan Manzi²⁶, Munther A. Khamashta²⁷, Ronald F. van Vollenhoven²⁸, Asad Zoma²⁹, Manuel Ramos-Casals³⁰, Guillermo Ruiz-Irastorza³¹, S. Sam Lim³², Thomas Stoll³³, Murat Inanc³⁴, Kenneth C. Kalunian³⁵, Diane L. Kamen³⁶, Peter Maddison³⁷, Christine A. Peschken³⁸, Søren Jacobsen³⁹, Anca Askanase⁴⁰, Jill P. Buyon⁴¹, Chris Theriault⁴², Kara Thompson⁴² and Vernon Farewell², ¹Division of Rheumatology, Dalhousie University and Capital Health, Nova Scotia, Canada, Halifax, NS, Canada, ²MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, United Kingdom, ³Medicine, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁴Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutricion, Mexico city, Mexico, ⁵Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁶Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁷Division of Rheumatology and Clinical Epidemiology, McGill University, Montreal, Quebec, QC, Canada, ⁸Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ⁹Rheumatology, Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, ¹⁰Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹¹Centre for Rheumatology Research, Rayne Building, 4th Floor, Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, ¹²Centre for Rheumatology Research, University College London, London, United Kingdom, ¹³Rheumatology, SUNY-Downstate Medical Center, Brooklyn, NY, ¹⁴Medicine, Division of Rheumatology, Centre Hospitalier Universitaire de Quebec et Universite Laval, Quebec, QC, Canada, ¹⁵University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ¹⁶Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ¹⁷Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ¹⁸Kellgren Centre for Rheum, Arthritis Research UK Epidemiology Unit, Institution of Inflammation and Repair, University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, ¹⁹Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ²⁰Rheumatology, Northwestern University and Feinberg School of Medicine, Chicago, IL, ²¹Feinstein Institute for Medical Research, Mahasset, NY, ²²Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ²³Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ²⁴Centre for Rheumatology Research, Landspital University Hospital, Reykjavik, Iceland, ²⁵Department of Rheumatology, University Hospital Lund, Lund, Sweden, ²⁶Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ²⁷Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom, ²⁸Unit for clinical therapy research (ClinTrid), Karolinska Institute, Stockholm, Sweden, ²⁹Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, United Kingdom, ³⁰Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, ³¹Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain, ³²Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ³³Kantonsspital Geissbergstr, Schaffhausen, Switzerland, ³⁴Rheumatology, Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey, ³⁵UCSD School of Medicine, La Jolla, CA, ³⁶Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, ³⁷Ysbyty Gwynedd Bangor, North Wales, United Kingdom, ³⁸University of Manitoba, Canada, Winnipeg, MB, Canada, ³⁹Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, ⁴⁰Columbia University Medical Center, New York, NY, ⁴¹Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁴²Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada
Background/Purpose: Neuropsychiatric (NP) events in patients with SLE include mood disorders. We determined the frequency, characteristics, clinical and autoantibody associations of mood disorders in a…
Abstract Number: 2397 • 2014 ACR/ARHP Annual Meeting
Improvement of Fatigue in Patients with Rheumatoid Arthritis Treated with Biologics: Relationship with Sleep Disorders, Depression and Clinical Efficacy. a Prospective, Multicenter Study
Marlène Genty¹, Marie Kostine², Elodie Ardouin³, Bernard Combe⁴ and Cédric Lukas⁵, ¹RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, ²Rheumatology, CHU Pellegrin, Bordeaux, France, ³Rheumatology, Limoges University Hospital, Limoges, France, ⁴Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, ⁵Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France
Background/Purpose The functional burden of disease in Rheumatoid arthritis (RA) patients, mainly caused by inflamed joints, is often worsened by extra-articular manifestations, among which asthenia remains…
Abstract Number: 2056 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Symptoms Beyond the Pain and Its Impact on the Patient
Abdelmoneim Helal¹, Dia MF Mohasseb², Noha AH El-Sawy² and Yousra H. Abdel-Fattah³, ¹Physical Medicine, Rheumatology & rehabilitation, Professor, Alexandria, Egypt, ²Physical Medicine, Rheumatology and Rehabilitation, Professor, Alexandria, Egypt, ³Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
Background/Purpose: Fibromyalgia (FM) has been promoted as the commonest cause of chronic, widespread non-articular musculoskeletal pain, stiffness and fatigue. Although pain is the central feature…
Abstract Number: 1811 • 2014 ACR/ARHP Annual Meeting
The Burden of Depression on Healthcare Utilization in a Population-Based Cohort of Patients with Systemic Lupus Erythematosus
Alfredo Aguirre¹, Gaobin Bao², S. Sam Lim³ and Cristina Drenkard⁴, ¹Department of Rheumatology, Emory University, Atlanta, GA, ²Medicine, Emory University, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Medicine, Div Rheumatology, Emory University, Atlanta, GA
Background/Purpose . Systemic lupus erythematosus (SLE) is a chronic disease that disproportionately strikes black women. Depression is a potentially debilitating co-morbidity that affects 15-75% of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].